283 YuanY.ZhengY.ZhangX.ChenY.WuX.WuJ.et al (2017)
Roses integrative approach to kidney detoxification challenges conventional nephrology, proving that kidney function can be restored, toxic burden reduced, and methylation pathways optimizedhelping patients avoid the downward spiral toward dialysis and systemic disease
A successful vote on the clinical-need question should not be rewritten as proof that BPC-157 heals tendons, ligaments, muscles, or the gastrointestinal tract in people
Others, including proponents of oral peptide formulations, suggest that short peptides like EpitalON may retain some activity when taken orally, particularly when formulated appropriately

NAD+ vs NMN vs NR (and IV vs SubQ) NAD+ Delivery Comparison Feature Mechanism NAD+ Injection (SubQ) Direct coenzyme delivery NAD+ Infusion (IV) Direct coenzyme delivery Oral NMN NAD+ precursor (converted in vivo) Oral NR (Niagen) NAD+ precursor (converted in vivo) Feature Typical research-planning dose NAD+ Injection (SubQ) 50-100 mg, 2-3x/week NAD+ Infusion (IV) 250-1,000 mg per session Oral NMN 300-600 mg/day Oral NR (Niagen) 300-1,000 mg/day Feature Speed to systemic NAD+ rise NAD+ Injection (SubQ) Hours NAD+ Infusion (IV) Minutes to hours Oral NMN Days to weeks Oral NR (Niagen) Days to weeks Feature Strongest human evidence NAD+ Injection (SubQ) Limited NAD+ Infusion (IV) Pilot PK and historical case reports Oral NMN Growing RCT base Oral NR (Niagen) Strongest RCT base Feature Convenience NAD+ Injection (SubQ) At-home injection technique required NAD+ Infusion (IV) Clinic visit, 2-4 hour infusion Oral NMN Daily oral capsule Oral NR (Niagen) Daily oral capsule Feature Regulatory status NAD+ Injection (SubQ) Not FDA-approved

These injections may be just what youre looking for